CARBOPLATIN PLUS WEEKLY NANOPARTICLE ALBUMIN-BOUND PACLITAXEL IN ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED SQUAMOUS NON-SMALL-CELL LUNG CANCER SELECTED BASED ON MINI NUTRITIONAL ASSESSMENT SHORT-FORM SCORES

Respirology ◽

10.1111/resp.13207_80 ◽

2017 ◽

Vol 22 ◽

pp. 115-115

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Nutritional Assessment ◽

Mini Nutritional Assessment ◽

Small Cell Lung

Download Full-text

Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-017-3385-7 ◽

2017 ◽

Vol 80 (3) ◽

pp. 461-467 ◽

Author(s):

Takayuki Shiroyama ◽

Motohiro Tamiya ◽

Seigo Minami ◽

So Takata ◽

Kentaro Masuhiro ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Nutritional Assessment ◽

Mini Nutritional Assessment ◽

Phase 2 ◽

Small Cell Lung ◽

Multicenter Phase ◽

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717964584.793468557 ◽

2013 ◽

Author(s):

Bruno Andreoni ◽

Gianmarco Contino

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Safety And Efficacy ◽

First Line Therapy ◽

Download Full-text

Faculty Opinions recommendation of Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725319285.793504410 ◽

2015 ◽

Author(s):

Paul Van Schil

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Stage I ◽

Small Cell Lung

Download Full-text

Faculty Opinions recommendation of Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725319285.793505174 ◽

2015 ◽

Author(s):

Adolfo Favaretto

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Stage I ◽

Small Cell Lung

Download Full-text

Faculty Opinions recommendation of Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726151262.793518485 ◽

2016 ◽

Author(s):

Maria-José Molina-Garrido

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Cell Lung Cancer ◽

Comprehensive Geriatric Assessment ◽

Phase Iii ◽

Small Cell Lung

Download Full-text

Corrigendum: Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba

Current Oncology ◽

10.3747//co.19.1012 ◽

2012 ◽

Vol 19 (1) ◽

Author(s):

Current Oncology

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Treatment Patterns ◽

Small Cell Lung

Download Full-text

Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients with Unresectable Stage III Non-Small-Cell Lung Cancer (PACIFIC)

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.05.009 ◽

2021 ◽

Author(s):

Mark A. Socinski ◽

Mustafa Özgüroğlu ◽

Augusto Villegas ◽

Davey Daniel ◽

David Vicente ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-020-04055-7 ◽

2020 ◽

Vol 85 (4) ◽

pp. 761-771 ◽

Author(s):

Ou Yamaguchi ◽

Hisao Imai ◽

Hiroyuki Minemura ◽

Kensuke Suzuki ◽

Satoshi Wasamoto ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Efficacy And Safety ◽

Small Cell Lung

Download Full-text

EP1.04-26 Efficacy and Safety of Anti-PD-1 Inhibitors in Elderly Patients with Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.2151 ◽

2019 ◽

Vol 14 (10) ◽

pp. S979-S980

Author(s):

Y. Tanaka ◽

T. Okano ◽

Y. Kudo ◽

S. Takeuchi ◽

Y. Makino ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Efficacy And Safety ◽

Small Cell Lung

Download Full-text

Phase I and pharmacokinetic (PK) study of Nedaplatin (254-S) in elderly patients with advanced non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(00)80223-8 ◽

2000 ◽

Vol 29 (1) ◽

pp. 69 ◽

Author(s):

T Kurata ◽

T Tamura ◽

N Yamamoto ◽

I Sekine ◽

H Kunitoh ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung

Download Full-text